AstraZeneca PLC AZN-GB:London Stock Exchange

RT Quote | Exchange | GBp
Last | 10:35 AM BST
9,032.00quote price arrow up+38.00 (+0.42%)
52 week range
6,499.80 - 9,149.00
Loading...
  • Open8,979.00
  • Day High9,041.00
  • Day Low8,935.00
  • Prev Close8,994.00
  • 52 Week High9,149.00
  • 52 Week High Date10/27/21
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21

Key Stats

  • Market Cap162,894.3M
  • Shares Out1,312.79M
  • 10 Day Average Volume1.18M
  • Dividend202.20
  • Dividend Yield2.24%
  • Beta0.16
  • YTD % Change23.1

KEY STATS

  • Open8,979.00
  • Day High9,041.00
  • Day Low8,935.00
  • Prev Close8,994.00
  • 52 Week High9,149.00
  • 52 Week High Date10/27/21
  • 52 Week Low6,499.80
  • 52 Week Low Date05/21/21
  • Market Cap162,894.3M
  • Shares Out1,312.79M
  • 10 Day Average Volume1.18M
  • Dividend202.20
  • Dividend Yield2.24%
  • Beta0.16
  • YTD % Change23.1

RATIOS/PROFITABILITY

  • EPS (TTM)207.66
  • P/E (TTM)43.49
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date08/12/2021
  • Div Amount64.80
  • Split Date-
  • Split Factor-

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
AstraZeneca PLC is a biopharmaceutical company. It focuses on discovery and development of products, which are then manufactured, marketed and sold. It focuses on three main therapy areas: Oncology, Cardiovascular, Renal & Metabolic (CVRM) and Respiratory, while selectively pursuing therapies in Autoimmunity, Infection and Neuroscience. In CVRM, it is expanding its portfolio into the cardiovascular-renal area with roxadustat, as well as investing to explore the benefits of...
Leif Johansson
Non-Executive Chairman
Pascal Soriot
Chief Executive Officer
Aradhana Sarin M.D.
Chief Financial Officer
Ruud Dobber Ph.D.
Executive Vice President
Menelas Pangalos
Executive Vice President
Address
1 Francis Crick Avenue
Cambridge
CB2 0AA
United Kingdom